These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4363713)

  • 21. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
    Newmaster RS; Mylin LM; Fu TM; Tevethia SS
    Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro sensitization and induction of syngeneic tumor--specific cell--mediated cytotoxicity.
    Ferguson RM; Moe M; Simmons RL
    Surg Forum; 1976; 27(62):117-9. PubMed ID: 1032910
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitative lung colony assay for tumor immunity in mice.
    Boone CW; Lundberg E; Orme T; Gillette R
    J Natl Cancer Inst; 1973 Nov; 51(5):1731-4. PubMed ID: 4357767
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumor rejection and immunotherapy studies with simian virus 40-induced tumors.
    Blakeslee JR; von Muenchhausen W; Cox HR
    J Med; 1973; 4(4):233-47. PubMed ID: 4358481
    [No Abstract]   [Full Text] [Related]  

  • 25. Cellular immunity to SV40-induced tumor cells and solubilized tumor-associated antigens in immune mice using an isotopic footpad assay.
    Dean JH; Lewis DD; Padarathsingh ML; McCoy JL; Northing JW; Natori T; Law LW
    Int J Cancer; 1977 Dec; 20(6):951-9. PubMed ID: 201575
    [No Abstract]   [Full Text] [Related]  

  • 26. Potentiation of cytotoxic T-cell function by virus.
    Reinisch CL; Schlossman SF
    J Natl Cancer Inst; 1976 Dec; 57(6):1277-81. PubMed ID: 63565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of simian virus 40 (SV40) transplantation immunity in mice by SV40-transformed cells of various species.
    Law LW; Takemoto KK; Rogers MJ; Ting RC
    J Natl Cancer Inst; 1977 Nov; 59(5):1523-6. PubMed ID: 198568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response of the Syrian golden hamster to SV40 induced and transplantable tumors.
    Goldrosen MH; Dent PB
    Fed Proc; 1978 May; 37(7):2092-5. PubMed ID: 205442
    [No Abstract]   [Full Text] [Related]  

  • 29. Augmented immunogenicity of tumor cell homogenates infected with influenza virus.
    Boone CW; Blackman K
    Cancer Res; 1972 May; 32(5):1018-22. PubMed ID: 4336024
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors.
    Chapes SK; Gooding LR
    J Immunol; 1985 Sep; 135(3):2192-8. PubMed ID: 2991384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo methods for the assessment of cell-mediated tumor immunity.
    Bartlett GL
    Natl Cancer Inst Monogr; 1972 Dec; 35():27-32. PubMed ID: 4659049
    [No Abstract]   [Full Text] [Related]  

  • 32. Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejection.
    Zarling JM; Tevethia SS
    J Natl Cancer Inst; 1973 Jan; 50(1):149-57. PubMed ID: 4348219
    [No Abstract]   [Full Text] [Related]  

  • 33. Low dose tolerance preventing tumor immunity.
    Kölsch E; Mengersen R; Diller E
    Eur J Cancer (1965); 1973; 9(11-12):879-82. PubMed ID: 4216506
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency.
    Grimm E; Bonavida B
    J Immunol; 1979 Dec; 123(6):2861-9. PubMed ID: 315432
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune response to a transplantable malignant melanoma in mice.
    Bartholomaeus WN; Bray AE; Papadimitriou JM; Keast D
    J Natl Cancer Inst; 1974 Oct; 53(4):1065-72. PubMed ID: 4547798
    [No Abstract]   [Full Text] [Related]  

  • 36. Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice.
    Glaser M
    J Natl Cancer Inst; 1978 Nov; 61(5):1351-5. PubMed ID: 213615
    [No Abstract]   [Full Text] [Related]  

  • 37. Fc gamma receptors play a dominant role in protective tumor immunity against a virus-encoded tumor-specific antigen in a murine model of experimental pulmonary metastases.
    Lowe DB; Shearer MH; Jumper CA; Bright RK; Kennedy RC
    J Virol; 2007 Feb; 81(3):1313-8. PubMed ID: 17108042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro evidence of specific BCG-induced immunity to malignant melanoma in BALB-c mice.
    Faraci RP; Barone JJ; Marrone JC; Schour L
    J Natl Cancer Inst; 1974 Jun; 52(6):1913-5. PubMed ID: 4834418
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
    Ruddle NH; Armstrong MY; Richards FF
    J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
    [No Abstract]   [Full Text] [Related]  

  • 40. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG.
    Tracey DE; Wolfe SA; Durdik JM; Henney CS
    J Immunol; 1977 Sep; 119(3):1145-51. PubMed ID: 330748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.